A patent review on HMGB1 inhibitors for the treatment of liver diseases
Article in Expert Opinion on Therapeutic Patents (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
The acidic intrinsically disordered region of the inflammatory mediator HMGB1 mediates fuzzy interactions with chemokine CXCL12
Preprint in bioRxiv (June 2023)
CXCL12/CXCR4 Axis is Involved in the Recruitment of NK Cells by HMGB1 Contributing to Persistent Airway Inflammation and AHR During the Late Stage of RSV Infection
Article in Journal of Microbiology (February 2023)